Physician-researcher at the Sharrett Institute of Oncology at Hadassah Medical, Principal Investigator at the Hadassah Cancer Research Institute and Senior Lecturer at the Hebrew University of Jerusalem Israel.
Dr. Moss’s research focuses on translational cancer biology, with an emphasis on circulating cell-free DNA and liquid biopsy technologies. Using computational and AI-based approaches combined with cutting-edge genomic approaches such as next-generation sequencing and nanopore sequencing, his lab studies DNA methylation and other DNA modification patterns to improve cancer detection, disease monitoring, and personalized treatment strategies.
Dr. Moss integrates clinical oncology with data-driven research and collaborates closely with academic and industry partners to translate discoveries into clinical application.